Four Pharma Companies in the Moscow Region to Receive Subsidies

23 January 2020

GMP News

There is a summary on the results of the meeting held by Moscow Region Ministry of Investments and Innovations tender commission on granting a subsidy to industrial enterprises for the creation of utility infrastructure facilities. According to the Deputy Prime Minister of the Moscow Region Vadim Khromov, the commission approved eight applications from investors who have erected their enterprises in the territory of Dubna, Stupino, Serpukhov, and Istra. Four of them belong to the medical and pharmaceutical industry.

The total amount of compensation to be received by investors as part recovering costs for building utility infrastructure facilities in 2019 is almost RUB220 million. More than half (RUB 115,732,172 million) is intended for medical and pharmaceutical companies. These include FP Obolenskoye JSC, Biofarmlab LLC, GranatBioTech LLC and PSK Pharma LLC.

“The commission results re-demonstrate that the program is available and functioning, and all applicants receive subsidies provided all conditions are met. Undoubtedly, this type of support will continue next year, and we encourage investors to participate in this programme,” Deputy Chairman Vadim Khromov said.

As part of this support programme, the Moscow Region government will reimburse the region’s residents for the costs incurred to implement industrial investment projects aimed at creating utility infrastructure facilities: gas supply, power supply, heat supply and treatment facilities.

The Moscow Region government is assisting medical and pharmaceutical companies in providing subsidies and tax exemptions. The Development Corporation of the Moscow Region provides consulting services.

“We provide comprehensive support of investment projects in the Moscow region, namely, we help to choose a site, to prepare documents to receive supportive measures, we cooperate with authorities on behalf of the investor. All this helps medical and pharmaceutical companies to effectively implement their projects, – Deputy General Director of the Moscow Region Development Corporation Alexander Fedorov says. – The pharmaceutical industry in the Moscow Region is developing quite rapidly. The Dubna special economic zone has already hosted a large medical and pharmaceutical cluster, which attracts new players.”

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more